Themis Medicare's Stock Sees 7.61% Increase, Outperforms Pharmaceutical Industry and Sensex

Themis Medicare, a smallcap pharmaceutical company, saw a 7.61% increase in its stock price on September 20, 2024. This rise in stock price was in line with the overall positive trend in the pharmaceutical industry. MarketsMOJO, a leading stock analysis platform, has given a 'Hold' call for Themis Medicare's stock.

The stock is currently trading at a price that is 4.88% away from its 52-week high of Rs 288. This indicates a strong performance by the company in the recent past. In fact, on the day of the price increase, Themis Medicare outperformed the sector by 5.72%.

Moreover, the stock has shown a trend reversal as it has gained after three consecutive days of fall. This indicates a positive sentiment among investors towards the company. The stock also touched an intraday high of Rs 275.5, which is a 6.45% increase from its previous close.

In terms of moving averages, Themis Medicare is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This further strengthens the positive outlook for the company's stock.

In comparison to the overall performance of the stock market, Themis Medicare has outperformed the Sensex by a significant margin. Its 1-day performance was 7.61% compared to the Sensex's 1.47%, and its 1-month performance was 5.55% compared to the Sensex's 4.47%.

Overall, Themis Medicare's stock has shown a strong performance and positive trend in the recent past, making it a promising investment option for investors.